ID   FYV1_HUMAN              Reviewed;        2098 AA.
AC   Q9Y2I7; Q08AR7; Q08AR8; Q53ST3; Q53T36; Q8N5H0; Q8NB67;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 3.
DT   10-MAY-2017, entry version 169.
DE   RecName: Full=1-phosphatidylinositol 3-phosphate 5-kinase;
DE            Short=Phosphatidylinositol 3-phosphate 5-kinase;
DE            EC=2.7.1.150;
DE   AltName: Full=FYVE finger-containing phosphoinositide kinase;
DE   AltName: Full=PIKfyve;
DE   AltName: Full=Phosphatidylinositol 3-phosphate 5-kinase type III;
DE            Short=PIPkin-III;
DE            Short=Type III PIP kinase;
GN   Name=PIKFYVE; Synonyms=KIAA0981, PIP5K3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ASN-696; SER-932;
RP   LEU-995; SER-998 AND LYS-1183.
RC   TISSUE=Brain;
RA   Cabezas A., Pattni K., Stenmark H.;
RT   "Human PIKfyve, a PI3P 5-kinase that regulates endocytic
RT   trafficking.";
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS ASN-696;
RP   SER-932; LEU-995; SER-998 AND LYS-1183.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1037-2098 (ISOFORM 1), AND
RP   VARIANT LYS-1183.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1521-2098 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11706043; DOI=10.1074/jbc.M110194200;
RA   Sbrissa D., Ikonomov O.C., Shisheva A.;
RT   "Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve.
RT   Binding specificity and role in PIKfyve endomembrane localization.";
RL   J. Biol. Chem. 277:6073-6079(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE PI(3,5)P2
RP   REGULATORY COMPLEX.
RX   PubMed=17556371; DOI=10.1074/jbc.M611678200;
RA   Sbrissa D., Ikonomov O.C., Fu Z., Ijuin T., Gruenberg J., Takenawa T.,
RA   Shisheva A.;
RT   "Core protein machinery for mammalian phosphatidylinositol 3,5-
RT   bisphosphate synthesis and turnover that regulates the progression of
RT   endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve
RT   complex.";
RL   J. Biol. Chem. 282:23878-23891(2007).
RN   [11]
RP   IDENTIFICATION IN THE PI(3,5)P2 REGULATORY COMPLEX.
RX   PubMed=18950639; DOI=10.1016/j.jmb.2008.10.009;
RA   Sbrissa D., Ikonomov O.C., Fenner H., Shisheva A.;
RT   "ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and
RT   Sac3 in a complex to promote PIKfyve activity and functionality.";
RL   J. Mol. Biol. 384:766-779(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299 AND SER-1544, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-299; SER-1544; SER-1549 AND SER-1754, CLEAVAGE
RP   OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION AT SER-318.
RX   PubMed=20513353; DOI=10.1016/j.bbrc.2010.05.134;
RA   Hill E.V., Hudson C.A., Vertommen D., Rider M.H., Tavare J.M.;
RT   "Regulation of PIKfyve phosphorylation by insulin and osmotic
RT   stress.";
RL   Biochem. Biophys. Res. Commun. 397:650-655(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; SER-88; SER-299;
RP   SER-307; SER-1544 AND SER-1549, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   VARIANT CFD ARG-1103.
RX   PubMed=15902656; DOI=10.1086/431346;
RA   Li S., Tiab L., Jiao X., Munier F.L., Zografos L., Frueh B.E.,
RA   Sergeev Y., Smith J., Rubin B., Meallet M.A., Forster R.K.,
RA   Hejtmancik J.F., Schorderet D.F.;
RT   "Mutations in PIP5K3 are associated with Francois-Neetens mouchetee
RT   fleck corneal dystrophy.";
RL   Am. J. Hum. Genet. 77:54-63(2005).
CC   -!- FUNCTION: The PI(3,5)P2 regulatory complex regulates both the
CC       synthesis and turnover of phosphatidylinositol 3,5-bisphosphate
CC       (PtdIns(3,5)P2). Catalyzes the phosphorylation of
CC       phosphatidylinositol 3-phosphate on the fifth hydroxyl of the myo-
CC       inositol ring, to form phosphatidylinositol 3,5-bisphosphate.
CC       Required for endocytic-vacuolar pathway and nuclear migration.
CC       Plays a role in the biogenesis of endosome carrier vesicles (ECV)/
CC       multivesicular bodies (MVB) transport intermediates from early
CC       endosomes. {ECO:0000269|PubMed:17556371}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 3-
CC       phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate.
CC   -!- SUBUNIT: Component of the PI(3,5)P2 regulatory complex/PAS
CC       complex, at least composed of PIKFYVE, FIG4 and VAC14. VAC14
CC       nucleates the assembly of the complex and serves as a scaffold.
CC       {ECO:0000269|PubMed:17556371, ECO:0000269|PubMed:18950639}.
CC   -!- INTERACTION:
CC       Q08AM6:VAC14; NbExp=4; IntAct=EBI-6138650, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Endosome membrane
CC       {ECO:0000269|PubMed:11706043, ECO:0000269|PubMed:17556371}.
CC       Note=Mainly associated with membranes of the late endocytic
CC       pathway.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9Y2I7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y2I7-2; Sequence=VSP_040108, VSP_040110, VSP_040111;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9Y2I7-3; Sequence=VSP_040109, VSP_040110, VSP_040111;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9Y2I7-4; Sequence=VSP_040110, VSP_040111;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated in response to insulin at Ser-318 in a protein
CC       kinase B (PKB)-dependent manner. {ECO:0000269|PubMed:20513353}.
CC   -!- DISEASE: Corneal dystrophy, fleck (CFD) [MIM:121850]: A form of
CC       stromal corneal dystrophy characterized by numerous small white
CC       flecks scattered in all levels of the stroma, with configurations
CC       varying from semicircular to wreath-like, curvilinear, or
CC       punctate. Although CFD may occasionally cause mild photophobia,
CC       patients are typically asymptomatic and have normal vision.
CC       {ECO:0000269|PubMed:15902656}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03674.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY457063; AAR19397.1; -; mRNA.
DR   EMBL; AC012362; AAY14870.1; -; Genomic_DNA.
DR   EMBL; AC016697; AAX93222.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70444.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70445.1; -; Genomic_DNA.
DR   EMBL; BC032389; AAH32389.1; -; mRNA.
DR   EMBL; BC125052; AAI25053.1; -; mRNA.
DR   EMBL; BC125053; AAI25054.1; -; mRNA.
DR   EMBL; AK091482; BAC03674.1; ALT_INIT; mRNA.
DR   EMBL; AB023198; BAA76825.1; -; mRNA.
DR   CCDS; CCDS2382.1; -. [Q9Y2I7-1]
DR   CCDS; CCDS33368.1; -. [Q9Y2I7-2]
DR   CCDS; CCDS54431.1; -. [Q9Y2I7-4]
DR   RefSeq; NP_001171471.1; NM_001178000.1. [Q9Y2I7-4]
DR   RefSeq; NP_055855.2; NM_015040.3. [Q9Y2I7-1]
DR   RefSeq; NP_689884.1; NM_152671.3. [Q9Y2I7-2]
DR   UniGene; Hs.744997; -.
DR   ProteinModelPortal; Q9Y2I7; -.
DR   SMR; Q9Y2I7; -.
DR   BioGrid; 128336; 10.
DR   IntAct; Q9Y2I7; 3.
DR   MINT; MINT-3084529; -.
DR   STRING; 9606.ENSP00000264380; -.
DR   ChEMBL; CHEMBL1938222; -.
DR   iPTMnet; Q9Y2I7; -.
DR   PhosphoSitePlus; Q9Y2I7; -.
DR   BioMuta; PIKFYVE; -.
DR   DMDM; 300669693; -.
DR   EPD; Q9Y2I7; -.
DR   PaxDb; Q9Y2I7; -.
DR   PeptideAtlas; Q9Y2I7; -.
DR   PRIDE; Q9Y2I7; -.
DR   DNASU; 200576; -.
DR   Ensembl; ENST00000264380; ENSP00000264380; ENSG00000115020. [Q9Y2I7-1]
DR   Ensembl; ENST00000308862; ENSP00000308715; ENSG00000115020. [Q9Y2I7-3]
DR   Ensembl; ENST00000392202; ENSP00000376038; ENSG00000115020. [Q9Y2I7-2]
DR   Ensembl; ENST00000407449; ENSP00000384356; ENSG00000115020. [Q9Y2I7-4]
DR   GeneID; 200576; -.
DR   KEGG; hsa:200576; -.
DR   UCSC; uc002vcv.4; human. [Q9Y2I7-1]
DR   CTD; 200576; -.
DR   DisGeNET; 200576; -.
DR   GeneCards; PIKFYVE; -.
DR   HGNC; HGNC:23785; PIKFYVE.
DR   HPA; HPA042604; -.
DR   MalaCards; PIKFYVE; -.
DR   MIM; 121850; phenotype.
DR   MIM; 609414; gene.
DR   neXtProt; NX_Q9Y2I7; -.
DR   OpenTargets; ENSG00000115020; -.
DR   Orphanet; 98970; Fleck corneal dystrophy.
DR   PharmGKB; PA165697116; -.
DR   eggNOG; ENOG410IMP3; Eukaryota.
DR   eggNOG; KOG0230; Eukaryota.
DR   eggNOG; COG0459; LUCA.
DR   eggNOG; COG5253; LUCA.
DR   GeneTree; ENSGT00840000129741; -.
DR   HOGENOM; HOG000059273; -.
DR   HOVERGEN; HBG072055; -.
DR   InParanoid; Q9Y2I7; -.
DR   KO; K00921; -.
DR   OMA; NRTTETE; -.
DR   OrthoDB; EOG091G00JB; -.
DR   PhylomeDB; Q9Y2I7; -.
DR   TreeFam; TF321717; -.
DR   BioCyc; MetaCyc:HS03825-MONOMER; -.
DR   BRENDA; 2.7.1.150; 2681.
DR   BRENDA; 2.7.1.68; 2681.
DR   Reactome; R-HSA-1660514; Synthesis of PIPs at the Golgi membrane.
DR   Reactome; R-HSA-1660516; Synthesis of PIPs at the early endosome membrane.
DR   Reactome; R-HSA-1660517; Synthesis of PIPs at the late endosome membrane.
DR   SIGNOR; Q9Y2I7; -.
DR   ChiTaRS; PIKFYVE; human.
DR   GeneWiki; PIKFYVE; -.
DR   GenomeRNAi; 200576; -.
DR   PRO; PR:Q9Y2I7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115020; -.
DR   CleanEx; HS_PIP5K3; -.
DR   ExpressionAtlas; Q9Y2I7; baseline and differential.
DR   Genevisible; Q9Y2I7; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0031901; C:early endosome membrane; IDA:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0031902; C:late endosome membrane; TAS:Reactome.
DR   GO; GO:0045121; C:membrane raft; IDA:HGNC.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0012506; C:vesicle membrane; IEA:Ensembl.
DR   GO; GO:0000285; F:1-phosphatidylinositol-3-phosphate 5-kinase activity; IBA:GO_Central.
DR   GO; GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; TAS:HGNC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0043813; F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0032288; P:myelin assembly; IEA:Ensembl.
DR   GO; GO:1904562; P:phosphatidylinositol 5-phosphate metabolic process; IC:ParkinsonsUK-UCL.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0034504; P:protein localization to nucleus; IMP:UniProtKB.
DR   GO; GO:2000785; P:regulation of autophagosome assembly; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   Gene3D; 3.30.800.10; -; 1.
DR   Gene3D; 3.30.810.10; -; 2.
DR   Gene3D; 3.50.7.10; -; 1.
DR   InterPro; IPR002423; Cpn60/TCP-1.
DR   InterPro; IPR000591; DEP_dom.
DR   InterPro; IPR027409; GroEL-like_apical_dom.
DR   InterPro; IPR027483; PInositol-4-P-5-kinase_C.
DR   InterPro; IPR002498; PInositol-4-P-5-kinase_core.
DR   InterPro; IPR027484; PInositol-4-P-5-kinase_N.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   InterPro; IPR000306; Znf_FYVE.
DR   InterPro; IPR017455; Znf_FYVE-rel.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00118; Cpn60_TCP1; 1.
DR   Pfam; PF00610; DEP; 1.
DR   Pfam; PF01363; FYVE; 1.
DR   Pfam; PF01504; PIP5K; 2.
DR   SMART; SM00049; DEP; 1.
DR   SMART; SM00064; FYVE; 1.
DR   SMART; SM00330; PIPKc; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF52029; SSF52029; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS50186; DEP; 1.
DR   PROSITE; PS51455; PIPK; 1.
DR   PROSITE; PS50178; ZF_FYVE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Corneal dystrophy; Disease mutation; Endosome; Kinase; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2   2098       1-phosphatidylinositol 3-phosphate 5-
FT                                kinase.
FT                                /FTId=PRO_0000185452.
FT   DOMAIN      365    440       DEP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00066}.
FT   DOMAIN     1758   2084       PIPK. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00781}.
FT   ZN_FING     158    218       FYVE-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00091}.
FT   REGION     1842   2098       Catalytic.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      88     88       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     299    299       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     307    307       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     312    312       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1T6}.
FT   MOD_RES     318    318       Phosphoserine; by PKB/AKT1 or PKB/AKT2.
FT                                {ECO:0000269|PubMed:20513353}.
FT   MOD_RES     329    329       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     475    475       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1T6}.
FT   MOD_RES    1544   1544       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1549   1549       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1754   1754       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ     108    204       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040108.
FT   VAR_SEQ     109    203       TRRKAEPTFGGHDPRTAVQLRSLSTVLKRLKEIMEGKSQDS
FT                                DLKQYWMPDSQCKECYDCSEKFTTFRRRHHCRLCGQIFCSR
FT                                CCNQEIPGKFMGY -> NSLQHPQEN (in isoform
FT                                3). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040109.
FT   VAR_SEQ     546    548       EYL -> GRR (in isoform 2, isoform 3 and
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040110.
FT   VAR_SEQ     549   2098       Missing (in isoform 2, isoform 3 and
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040111.
FT   VARIANT     617    617       M -> V (in dbSNP:rs16840913).
FT                                /FTId=VAR_057097.
FT   VARIANT     696    696       S -> N (in dbSNP:rs10932258).
FT                                {ECO:0000269|Ref.1, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_063406.
FT   VARIANT     932    932       L -> S (in dbSNP:rs2363468).
FT                                {ECO:0000269|Ref.1, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_063407.
FT   VARIANT     995    995       Q -> L (in dbSNP:rs893254).
FT                                {ECO:0000269|Ref.1, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_063408.
FT   VARIANT     998    998       T -> S (in dbSNP:rs893253).
FT                                {ECO:0000269|Ref.1, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_063409.
FT   VARIANT    1033   1033       S -> A (in dbSNP:rs999890).
FT                                /FTId=VAR_057098.
FT   VARIANT    1103   1103       K -> R (in CFD; dbSNP:rs121918336).
FT                                {ECO:0000269|PubMed:15902656}.
FT                                /FTId=VAR_025309.
FT   VARIANT    1183   1183       Q -> K (in dbSNP:rs1529979).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.1, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_063410.
FT   VARIANT    1858   1858       R -> Q (in dbSNP:rs2289170).
FT                                /FTId=VAR_057099.
FT   CONFLICT   1335   1335       M -> I (in Ref. 5; BAC03674).
FT                                {ECO:0000305}.
FT   CONFLICT   2019   2019       L -> S (in Ref. 5; BAC03674).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2098 AA;  237136 MW;  390C43530D3B1E81 CRC64;
     MATDDKTSPT LDSANDLPRS PTSPSHLTHF KPLTPDQDEP PFKSAYSSFV NLFRFNKERA
     EGGQGEQQPL SGSWTSPQLP SRTQSVRSPT PYKKQLNEEL QRRSSALDTR RKAEPTFGGH
     DPRTAVQLRS LSTVLKRLKE IMEGKSQDSD LKQYWMPDSQ CKECYDCSEK FTTFRRRHHC
     RLCGQIFCSR CCNQEIPGKF MGYTGDLRAC TYCRKIALSY AHSTDSNSIG EDLNALSDSA
     CSVSVLDPSE PRTPVGSRKA SRNIFLEDDL AWQSLIHPDS SNTPLSTRLV SVQEDAGKSP
     ARNRSASITN LSLDRSGSPM VPSYETSVSP QANRTYVRTE TTEDERKILL DSVQLKDLWK
     KICHHSSGME FQDHRYWLRT HPNCIVGKEL VNWLIRNGHI ATRAQAIAIG QAMVDGRWLD
     CVSHHDQLFR DEYALYRPLQ STEFSETPSP DSDSVNSVEG HSEPSWFKDI KFDDSDTEQI
     AEEGDDNLAN SASPSKRTSV SSFQSTVDSD SAASISLNVE LDNVNFHIKK PSKYPHVPPH
     PADQKEYLIS DTGGQQLSIS DAFIKESLFN RRVEEKSKEL PFTPLGWHHN NLELLREENG
     EKQAMERLLS ANHNHMMALL QQLLHSDSLS SSWRDIIVSL VCQVVQTVRP DVKNQDDDMD
     IRQFVHIKKI PGGKKFDSVV VNGFVCTKNI AHKKMSSCIK NPKILLLKCS IEYLYREETK
     FTCIDPIVLQ EREFLKNYVQ RIVDVRPTLV LVEKTVSRIA QDMLLEHGIT LVINVKSQVL
     ERISRMTQGD LVMSMDQLLT KPHLGTCHKF YMQIFQLPNE QTKTLMFFEG CPQHLGCTIK
     LRGGSDYELA RVKEILIFMI CVAYHSQLEI SFLMDEFAMP PTLMQNPSFH SLIEGRGHEG
     AVQEQYGGGS IPWDPDIPPE SLPCDDSSLL ELRIVFEKGE QENKNLPQAV ASVKHQEHST
     TACPAGLPCA FFAPVPESLL PLPVDDQQDA LGSEQPETLQ QTVVLQDPKS QIRAFRDPLQ
     DDTGLYVTEE VTSSEDKRKT YSLAFKQELK DVILCISPVI TFREPFLLTE KGMRCSTRDY
     FAEQVYWSPL LNKEFKEMEN RRKKQLLRDL SGLQGMNGSI QAKSIQVLPS HELVSTRIAE
     HLGDSQSLGR MLADYRARGG RIQPKNSDPF AHSKDASSTS SGQSGSKNEG DEERGLILSD
     AVWSTKVDCL NPINHQRLCV LFSSSSAQSS NAPSACVSPW IVTMEFYGKN DLTLGIFLER
     YCFRPSYQCP SMFCDTPMVH HIRRFVHGQG CVQIILKELD SPVPGYQHTI LTYSWCRICK
     QVTPVVALSN ESWSMSFAKY LELRFYGHQY TRRANAEPCG HSIHHDYHQY FSYNQMVASF
     SYSPIRLLEV CVPLPKIFIK RQAPLKVSLL QDLKDFFQKV SQVYVAIDER LASLKTDTFS
     KTREEKMEDI FAQKEMEEGE FKNWIEKMQA RLMSSSVDTP QQLQSVFESL IAKKQSLCEV
     LQAWNNRLQD LFQQEKGRKR PSVPPSPGRL RQGEESKISA MDASPRNISP GLQNGEKEDR
     FLTTLSSQSS TSSTHLQLPT PPEVMSEQSV GGPPELDTAS SSEDVFDGHL LGSTDSQVKE
     KSTMKAIFAN LLPGNSYNPI PFPFDPDKHY LMYEHERVPI AVCEKEPSSI IAFALSCKEY
     RNALEELSKA TQWNSAEEGL PTNSTSDSRP KSSSPIRLPE MSGGQTNRTT ETEPQPTKKA
     SGMLSFFRGT AGKSPDLSSQ KRETLRGADS AYYQVGQTGK EGTENQGVEP QDEVDGGDTQ
     KKQLINPHVE LQFSDANAKF YCRLYYAGEF HKMREVILDS SEEDFIRSLS HSSPWQARGG
     KSGAAFYATE DDRFILKQMP RLEVQSFLDF APHYFNYITN AVQQKRPTAL AKILGVYRIG
     YKNSQNNTEK KLDLLVMENL FYGRKMAQVF DLKGSLRNRN VKTDTGKESC DVVLLDENLL
     KMVRDNPLYI RSHSKAVLRT SIHSDSHFLS SHLIIDYSLL VGRDDTSNEL VVGIIDYIRT
     FTWDKKLEMV VKSTGILGGQ GKMPTVVSPE LYRTRFCEAM DKYFLMVPDH WTGLGLNC
//
